196 related articles for article (PubMed ID: 37967663)
41. Epigenetic aging and PTSD outcomes in the immediate aftermath of trauma.
Zannas AS; Linnstaedt SD; An X; Stevens JS; Harnett NG; Roeckner AR; Oliver KI; Rubinow DR; Binder EB; Koenen KC; Ressler KJ; McLean SA
Psychol Med; 2023 Nov; 53(15):7170-7179. PubMed ID: 36951141
[TBL] [Abstract][Full Text] [Related]
42. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers.
Janelidze S; Christian BT; Price J; Laymon C; Schupf N; Klunk WE; Lott I; Silverman W; Rosas HD; Zaman S; Mapstone M; Lai F; Ances BM; Handen BL; Hansson O
JAMA Neurol; 2022 Aug; 79(8):797-807. PubMed ID: 35789365
[TBL] [Abstract][Full Text] [Related]
43. Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
Ferreira PCL; Zhang Y; Snitz B; Chang CH; Bellaver B; Jacobsen E; Kamboh MI; Zetterberg H; Blennow K; Pascoal TA; Villemagne VL; Ganguli M; Karikari TK
Alzheimers Dement; 2023 Oct; 19(10):4507-4519. PubMed ID: 36876954
[TBL] [Abstract][Full Text] [Related]
44. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.
Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM
Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162
[TBL] [Abstract][Full Text] [Related]
45. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic aging as a biomarker of dementia and related outcomes: a systematic review.
Zhou A; Wu Z; Zaw Phyo AZ; Torres D; Vishwanath S; Ryan J
Epigenomics; 2022 Sep; 14(18):1125-1138. PubMed ID: 36154448
[TBL] [Abstract][Full Text] [Related]
47. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
48. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.
Syrjanen JA; Campbell MR; Algeciras-Schimnich A; Vemuri P; Graff-Radford J; Machulda MM; Bu G; Knopman DS; Jack CR; Petersen RC; Mielke MM
Alzheimers Dement; 2022 Jun; 18(6):1128-1140. PubMed ID: 34569696
[TBL] [Abstract][Full Text] [Related]
49. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
50. The association between personality and plasma biomarkers of astrogliosis and neuronal injury.
Terracciano A; Walker K; An Y; Luchetti M; Stephan Y; Moghekar AR; Sutin AR; Ferrucci L; Resnick SM
Neurobiol Aging; 2023 Aug; 128():65-73. PubMed ID: 37210782
[TBL] [Abstract][Full Text] [Related]
51. Alzheimer's pathology is associated with altered cognition, brain volume, and plasma biomarker patterns in traumatic encephalopathy syndrome.
Asken BM; Tanner JA; Gaynor LS; VandeVrede L; Mantyh WG; Casaletto KB; Staffaroni AM; Fonseca C; Shankar R; Grant H; Smith K; Lago AL; Xu H; La Joie R; Cobigo Y; Rosen H; Perry DC; Rojas JC; Miller BL; Gardner RC; Wang KKW; Kramer JH; Rabinovici GD
Alzheimers Res Ther; 2023 Jul; 15(1):126. PubMed ID: 37480088
[TBL] [Abstract][Full Text] [Related]
52. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
[TBL] [Abstract][Full Text] [Related]
53. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.
Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J
Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder.
Lima CNC; Suchting R; Scaini G; Cuellar VA; Favero-Campbell AD; Walss-Bass C; Soares JC; Quevedo J; Fries GR
Eur Neuropsychopharmacol; 2022 Sep; 62():10-21. PubMed ID: 35810614
[TBL] [Abstract][Full Text] [Related]
55. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old.
Pelkmans W; Legdeur N; Ten Kate M; Barkhof F; Yaqub MM; Holstege H; van Berckel BNM; Scheltens P; van der Flier WM; Visser PJ; Tijms BM
Ann Clin Transl Neurol; 2021 Feb; 8(2):348-358. PubMed ID: 33421355
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal Associations among Posttraumatic Stress Disorder Symptoms, Traumatic Brain Injury, and Neurocognitive Functioning in Army Soldiers Deployed to the Iraq War.
Vasterling JJ; Aslan M; Lee LO; Proctor SP; Ko J; Jacob S; Concato J
J Int Neuropsychol Soc; 2018 Apr; 24(4):311-323. PubMed ID: 29199924
[TBL] [Abstract][Full Text] [Related]
57. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
[TBL] [Abstract][Full Text] [Related]
58. Evaluating the impact of trauma and PTSD on epigenetic prediction of lifespan and neural integrity.
Katrinli S; Stevens J; Wani AH; Lori A; Kilaru V; van Rooij SJH; Hinrichs R; Powers A; Gillespie CF; Michopoulos V; Gautam A; Jett M; Hammamieh R; Yang R; Wildman D; Qu A; Koenen K; Aiello AE; Jovanovic T; Uddin M; Ressler KJ; Smith AK
Neuropsychopharmacology; 2020 Sep; 45(10):1609-1616. PubMed ID: 32380512
[TBL] [Abstract][Full Text] [Related]
59. Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
Stockmann J; Verberk IMW; Timmesfeld N; Denz R; Budde B; Lange-Leifhelm J; Scheltens P; van der Flier WM; Nabers A; Teunissen CE; Gerwert K
Alzheimers Res Ther; 2020 Dec; 12(1):169. PubMed ID: 33357241
[TBL] [Abstract][Full Text] [Related]
60. Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia.
Reas ET; Hagler DJ; Kuperman JM; Wierenga CE; Galasko D; White NS; Dale AM; Banks SJ; McEvoy LK; Brewer JB
J Alzheimers Dis; 2020; 73(1):347-357. PubMed ID: 31796676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
